ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,837Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 479

$949K Total Retail Price of All Prescriptions

Rank: 10 out of 479

521 Patients Receiving at Least One Drug in Part D
34%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

53% of this provider’s 521 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

4% of this provider’s 4,836 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $97 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
HYDROCODONE-ACETAMINOPHEN 928 273 S3 1 6
CARISOPRODOL 607 135 R 2 97
ZOLPIDEM TARTRATE 519 153 3 16
NEXIUM 336 86 4 15
SYMBICORT 274 86 5 85
PREDNISONE 264 111 6 25
SINGULAIR 261 99 7 46
EXFORGE 257 100 8 137
AZITHROMYCIN 242 98 9 35
ATORVASTATIN CALCIUM 208 85 10 10
MONTELUKAST SODIUM 204 68 11 116
CRESTOR 198 103 12 14
LYRICA 188 56 13 55
TRAMADOL HCL 175 81 14 24
AMLODIPINE BESYLATE-BENAZEPRIL 173 48 15 60
CLONIDINE HCL 166 66 16 121
OMEPRAZOLE 157 86 17 2
RAMIPRIL 155 87 18 83
PROAIR HFA 155 53 18 64
ZETIA 143 77 20 80
FUROSEMIDE 133 85 21 12
HYDROXYZINE HCL 130 30 R 22 130
ALCOHOL SWABS 126 89 23 197
NASONEX 120 51 24 166
FAMOTIDINE 113 39 25 89
METHOCARBAMOL 109 16 R 26 177
LANTUS SOLOSTAR 109 52 26 63
LEVOTHYROXINE SODIUM 107 46 28 3
CIPROFLOXACIN HCL 104 46 29 44
ESCITALOPRAM OXALATE 103 54 30 150
METFORMIN HCL 96 52 31 7
CELEBREX 96 18 31 68
PROVENTIL HFA 94 23 33 270
SPIRIVA 93 68 34 36
AMOX TR-POTASSIUM CLAVULANATE 91 30 35 227
CYMBALTA 90 20 36 90
VENTOLIN HFA 88 30 37 58
NAMENDA 86 80 38 67
CLOPIDOGREL 85 41 39 23
HYDROCHLOROTHIAZIDE 82 33 40 9
BYSTOLIC 79 31 41 118
LIPITOR 78 39 42 164
DIOVAN 75 36 43 39
ACETAMINOPHEN-CODEINE 75 50 S3 43 291
GLYBURIDE-METFORMIN HCL 72 31 R 45 113
METOPROLOL SUCCINATE 68 42 46 11
METOPROLOL TARTRATE 64 25 47 8
MOMETASONE FUROATE 63 23 48 151
PLAVIX 62 29 49 30
COREG CR 59 46 50 323
SEROQUEL XR 57 0 51 240
SYNTHROID 55 40 52 38
HUMALOG 55 26 52 178
AMLODIPINE BESYLATE 55 25 52 5
NATEGLINIDE 52 46 55 341
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.